STOCK TITAN

TriSalus Life Sciences Warrant (TLSIW) Stock Price, News & Analysis

TLSIW NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
101 161 sessions, September 9, 2025 to September 9, 2026
Largest daily move
+103.6% close of August 24, 2026
1-year change
-50.8% closing prices, September 9, 2025 to September 9, 2026

Company Description

TriSalus Life Sciences Warrant (NASDAQ: TLSIW) is classified in the surgical & medical instruments & apparatus industry.

TLSIW has declined 50.8% over the past year. The last closing price was $0.8900.

For FY2025, TriSalus Life Sciences Warrant reported revenue of $45.2M with net income of -$39.2M and diluted earnings per share of -$1.84. The company operates at a net profit margin of -86.9%.

This page collects what Stock Titan holds for TLSIW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
-
-
Last updated:
-50.8%
Performance 1 year

TriSalus Life Sciences Warrant (TLSIW) closed at $0.8900 on September 9, 2026. Over the past 12 months, the price has lost 50.8%.

See what a $1,000 investment in TLSIW would be worth today

TLSIW Metrics & Rankings

Month to date
+2.3%
View ranking
YTD
-46.4%
View ranking

Price returns through September 9, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

No recent news available for TLSIW.

SEC Filings

TriSalus Life Sciences Warrant has filed 5 recent SEC filings, including 2 Form 4, 1 Form 10-Q, 1 Form 8-K, 1 Form SCHEDULE 13G/A. The most recent filing was submitted on August 6, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TLSIW SEC filings →

Financial Highlights

TriSalus Life Sciences Warrant generated $45.2M in revenue in FY2025, retaining a 84.6% gross margin, operating income reached -$26.9M (-59.7% operating margin), and net income was -$39.2M, reflecting a -86.9% net profit margin. Diluted earnings per share stood at -$1.84. The company generated -$18.0M in operating cash flow. With a current ratio of 2.80, the balance sheet reflects a strong liquidity position.

$45.2M
Revenue (FY2025)
-$39.2M
Net Income (FY2025)
-$18.0M
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in TriSalus Life Sciences Warrant (TLSIW) currently stands at 16.3 thousand shares, down 20.8% from the previous reporting period. Since September 2025, short interest has increased by 471.6%. With 11.3 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.

Days to Cover History

Last 12 Months

Days to cover for TriSalus Life Sciences Warrant (TLSIW) currently stands at 11.3 days, up 81.9% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 880.9% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 11.3 days.

TLSIW Company Profile & Sector Positioning

TriSalus Life Sciences Warrant (TLSIW) and is listed on the NASDAQ.

Frequently Asked Questions

What is the current stock price of TriSalus Life Sciences Warrant (TLSIW)?

The current stock price of TriSalus Life Sciences Warrant (TLSIW) is $0.89 as of September 9, 2026.

What is the revenue of TriSalus Life Sciences Warrant (TLSIW) stock?

The FY2025 revenue of TriSalus Life Sciences Warrant (TLSIW) is $45.2M, from its most recent completed fiscal year.

What is the net income of TriSalus Life Sciences Warrant (TLSIW)?

The FY2025 net income of TriSalus Life Sciences Warrant (TLSIW) is -$39.2M, from its most recent completed fiscal year.

What is the earnings per share (EPS) of TriSalus Life Sciences Warrant (TLSIW)?

The diluted earnings per share (EPS) of TriSalus Life Sciences Warrant (TLSIW) is -$1.84 for FY2025, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of TriSalus Life Sciences Warrant (TLSIW)?

The operating cash flow of TriSalus Life Sciences Warrant (TLSIW) is -$18.0M. Learn about cash flow.

What is the profit margin of TriSalus Life Sciences Warrant (TLSIW)?

The net profit margin of TriSalus Life Sciences Warrant (TLSIW) is -86.9%. Learn about profit margins.

What is the operating margin of TriSalus Life Sciences Warrant (TLSIW)?

The operating profit margin of TriSalus Life Sciences Warrant (TLSIW) is -59.7%. Learn about operating margins.

What is the gross margin of TriSalus Life Sciences Warrant (TLSIW)?

The gross profit margin of TriSalus Life Sciences Warrant (TLSIW) is 84.6%. Learn about gross margins.

What is the current ratio of TriSalus Life Sciences Warrant (TLSIW)?

The current ratio of TriSalus Life Sciences Warrant (TLSIW) is 2.80, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of TriSalus Life Sciences Warrant (TLSIW)?

The gross profit of TriSalus Life Sciences Warrant (TLSIW) is $38.2M for FY2025, its most recent completed fiscal year.

What is the operating income of TriSalus Life Sciences Warrant (TLSIW)?

The operating income of TriSalus Life Sciences Warrant (TLSIW) is -$26.9M. Learn about operating income.